Video

What Makes A Good Therapeutic Cancer Vaccine Antigen?

Source: Bioprocess Online

In this segment of the Bioprocess Online Live event, HDT Bio Chief Scientific Officer Peter Berglund, Ph.D, Ph.D., Codagenix EVP for Oncology Johanna Kaufmann, Ph.D., and Providence Therapeutics President & Chief Technology Officer Robert Georgantas III, Ph.D. offer their thoughts on the attributes of a good tumor antigen, and address audience questions on the role of small molecules in oncology.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)